Velta Ose

Ratsupites Str. 1
Riga, RIX 1067, Latvia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine.

PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine.

Journal: Microorganisms

Published: December 20, 2022

Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.

Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates.

Journal: BMC biotechnology

Published: April 28, 2017

The True Story and Advantages of RNA Phage Capsids as Nanotools.

The True Story and Advantages of RNA Phage Capsids as Nanotools.

Journal: Intervirology

Published: May 25, 2016

The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.

The Hepatitis B Virus Core Variants that Expose Foreign C-Terminal Insertions on the Outer Surface of Virus-Like Particles.

Journal: Molecular biotechnology

Published: October 09, 2015

Potato Virus M-Like Nanoparticles: Construction and Characterization.

Potato Virus M-Like Nanoparticles: Construction and Characterization.

Journal: Molecular biotechnology

Published: September 09, 2015

Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.

Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.

Journal: Scientific reports

Published: February 08, 2015

Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

Journal: PloS one

Published: September 15, 2014

Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.

Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.

Journal: Molecular biotechnology

Published: February 27, 2014

Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.

Chimeric derivatives of hepatitis B virus core particles carrying major epitopes of the rubella virus E1 glycoprotein.

Journal: Clinical and vaccine immunology : CVI

Published: September 06, 2013

Yeast-expressed bacteriophage-like particles for the packaging of nanomaterials.

Yeast-expressed bacteriophage-like particles for the packaging of nanomaterials.

Journal: Molecular biotechnology

Published: July 16, 2013

A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.

A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.

Journal: PloS one

Published: April 29, 2013

Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.

Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.

Journal: Journal of viral hepatitis

Published: August 07, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026